06:01 PM EDT, 05/17/2024 (MT Newswires) -- Leonard S Schleifer, Director, Board Co-Chair, President & CEO, on May 17, 2024, sold 22,830 shares in Regeneron Pharmaceuticals ( REGN ) for $22,355,714. Following the Form 4 filing with the SEC, Schleifer has control over a total of 695,346 shares of the company, with 466,877 shares held directly and 228,469 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/872589/000188385024000025/xslF345X03/edgardoc.xml

Price: 965.00, Change: -17.29, Percent Change: -1.76